<- Go Home
Medicus Pharma Ltd.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Market Cap
$14.0M
Volume
272.8K
Cash and Equivalents
$8.7M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$8.94
52 Week Low
$0.25
Dividend
N/A
Price / Book Value
-124.86
Price / Earnings
-0.12
Price / Tangible Book Value
-124.86
Enterprise Value
$10.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$25.6M
Return on Equity
2981.18%
Return on Assets
-204.05
Cash and Short Term Investments
$8.7M
Debt
$5.5M
Equity
$37.3K
Revenue
N/A
Unlevered FCF
-$12.1M
Sector
Biotechnology
Category
N/A